Terms: = Prostate cancer AND TOP2A, TOP2, TP2A
44 results:
1. A Machine Learning Method for Predicting Biomarkers Associated with prostate cancer.
Tong Y; Tan Z; Wang P; Gao X
Front Biosci (Landmark Ed); 2023 Dec; 28(12):333. PubMed ID: 38179769
[TBL] [Abstract] [Full Text] [Related]
2. BAZ2A-RNA mediated association with top2a and KDM1A represses genes implicated in prostate cancer.
Roganowicz M; Bär D; Bersaglieri C; Aprigliano R; Santoro R
Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37184661
[TBL] [Abstract] [Full Text] [Related]
3. IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms.
Mei W; Dong Y; Gu Y; Kapoor A; Lin X; Su Y; Vega Neira S; Tang D
J Adv Res; 2023 Dec; 54():195-210. PubMed ID: 36681115
[TBL] [Abstract] [Full Text] [Related]
4. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer.
Huang RH; Hong YK; Du H; Ke WQ; Lin BB; Li YL
J Transl Med; 2023 Jan; 21(1):20. PubMed ID: 36635710
[TBL] [Abstract] [Full Text] [Related]
5. The 5-Hydroxymethylcytosine Landscape of prostate cancer.
Sjöström M; Zhao SG; Levy S; Zhang M; Ning Y; Shrestha R; Lundberg A; Herberts C; Foye A; Aggarwal R; Hua JT; Li H; Bergamaschi A; Maurice-Dror C; Maheshwari A; Chen S; Ng SWS; Ye W; Petricca J; Fraser M; Chesner L; Perry MD; Moreno-Rodriguez T; Chen WS; Alumkal JJ; Chou J; Morgans AK; Beer TM; Thomas GV; Gleave M; Lloyd P; Phillips T; McCarthy E; Haffner MC; Zoubeidi A; Annala M; Reiter RE; Rettig MB; Witte ON; Fong L; Bose R; Huang FW; Luo J; Bjartell A; Lang JM; Mahajan NP; Lara PN; Evans CP; Tran PT; Posadas EM; He C; Cui XL; Huang J; Zwart W; Gilbert LA; Maher CA; Boutros PC; Chi KN; Ashworth A; Small EJ; He HH; Wyatt AW; Quigley DA; Feng FY
Cancer Res; 2022 Nov; 82(21):3888-3902. PubMed ID: 36251389
[TBL] [Abstract] [Full Text] [Related]
6. Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of prostate cancer.
Wang W; Wu Q; Mohyeddin A; Liu Y; Liu Z; Ge J; Zhang B; Shi G; Wang W; Wu D; Wang F
Comput Math Methods Med; 2022; 2022():5500416. PubMed ID: 36245843
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Profile Changes in Patients with Castrate-Resistant prostate cancer Pre- and Post-Abiraterone/Prednisone Treatment.
Sicotte H; Kalari KR; Qin S; Dehm SM; Bhargava V; Gormley M; Tan W; Sinnwell JP; Hillman DW; Li Y; Vedell PT; Carlson RE; Bryce AH; Jimenez RE; Weinshilboum RM; Kohli M; Wang L
Mol Cancer Res; 2022 Dec; 20(12):1739-1750. PubMed ID: 36135372
[TBL] [Abstract] [Full Text] [Related]
8. Identification of senescence-related molecular subtypes and key genes for prostate cancer.
Feng DC; Zhu WZ; Shi X; Xiong Q; You J; Wei Q; Yang L
Asian J Androl; 2023; 25(2):223-229. PubMed ID: 36124532
[TBL] [Abstract] [Full Text] [Related]
9. Identification of novel biomarkers in prostate cancer diagnosis and prognosis.
Li W; Xu W; Sun K; Wang F; Wong TW; Kong AN
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23137. PubMed ID: 35686336
[TBL] [Abstract] [Full Text] [Related]
10. Targeting DNA topoisomerase IIα (top2a) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs).
Smith PJ; McKeown SR; Patterson LH
IUBMB Life; 2023 Jan; 75(1):40-54. PubMed ID: 35499745
[TBL] [Abstract] [Full Text] [Related]
11. Environmental Phenol and Paraben Exposure Risks and Their Potential Influence on the Gene Expression Involved in the Prognosis of prostate cancer.
Alwadi D; Felty Q; Roy D; Yoo C; Deoraj A
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409038
[TBL] [Abstract] [Full Text] [Related]
12. Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant prostate cancer.
Qin S; Gao H; Kim W; Zhang H; Gu Y; Kalari KR; Sinnwell JP; Scholz JA; Xie F; Yin P; Yu J; Qin B; Zhuang Y; Wei L; Tan W; Bryce AH; Weinshilboum RM; Wang L
Clin Pharmacol Ther; 2022 Jun; 111(6):1296-1306. PubMed ID: 35288936
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of recurrence from metabolites and expression of top2a and EZH2 in prostate cancer patients treated with radiotherapy.
Hansen AF; Høiem TS; Selnaes KM; Bofin AM; Størkersen Ø; Bertilsson H; Wright AJ; Giskeødegård GF; Bathen TF; Rye MB; Tessem MB
NMR Biomed; 2023 May; 36(5):e4694. PubMed ID: 35032074
[TBL] [Abstract] [Full Text] [Related]
14. Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways.
Hongo H; Kosaka T; Suzuki Y; Mikami S; Fukada J; Oya M
Sci Rep; 2021 Nov; 11(1):22284. PubMed ID: 34782700
[TBL] [Abstract] [Full Text] [Related]
15. Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary cancer Treatment-The Effect of Dose-Response on 2D and 3D Cell Cultures.
Kloskowski T; Szeliski K; Fekner Z; Rasmus M; Dąbrowski P; Wolska A; Siedlecka N; Adamowicz J; Drewa T; Pokrywczyńska M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769400
[TBL] [Abstract] [Full Text] [Related]
16. Drugging the 'undruggable'. Therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods.
Radaeva M; Ton AT; Hsing M; Ban F; Cherkasov A
Drug Discov Today; 2021 Nov; 26(11):2660-2679. PubMed ID: 34332092
[TBL] [Abstract] [Full Text] [Related]
17. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract] [Full Text] [Related]
18. Correlative analysis between two commercially available post-prostatectomy genomic tests.
Shahait M; Alshalalfa M; Nguyen PL; Al-Fahmawi A; Dobbs RW; Lal P; Lee DI
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):575-577. PubMed ID: 33750906
[TBL] [Abstract] [Full Text] [Related]
19. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
Wang Y; Wang J; Tang Q; Ren G
PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
[TBL] [Abstract] [Full Text] [Related]
20. MiRNA-145-5p expression and prospective molecular mechanisms in the metastasis of prostate cancer.
Huang ZG; Sun Y; Chen G; Dang YW; Lu HP; He J; Cheng JW; He ML; Li SH
IET Syst Biol; 2021 Feb; 15(1):1-13. PubMed ID: 33527765
[TBL] [Abstract] [Full Text] [Related]
[Next]
